Home > Our Doctors > Find a Doctor

Select Physicians to compare
Photo of Christine Szarka

Christine E Szarka , MD

Request an Appointment

Need help deciding?
Contact 1.866.CALL.MLH or
484.580.1000 for assistance.

Medical Group:

MLHC Hematology & Oncology Associates

Primary Office:

Main Line Health Center in Collegeville
599 Arcola Road
Collegeville, PA  19426

Office Phone: 484.565.1600
Main Line HealthCare Physician
Specialties Accepting New Patients
Oncology
  Board Certified in 1995
Yes
Hematology/Oncology Yes
Gender: F
Years in practice: 22
Areas of Clinical Interest: Advanced treatment for all cancer diagnoses, including:
- GI Malignancies
- Breast Cancer

Medical School:
Medical College of Pennsylvania

Residency:
Chandler Medical Center, University of Kentucky

Fellowship:
Fox Chase Cancer Center

Primary Affiliation:  Paoli Hospital

* Members of the Main Line Health medical staff are affiliated with Bryn Mawr Hospital, Lankenau Medical Center, Paoli Hospital and Riddle Hospital.

MLHC Hematology & Oncology Associates   (view other physicians at this practice)

Office Information

Location:
Cancer Center of Paoli Hospital
255 West Lancaster Avenue
Paoli, PA  19301

TEL: 484.565.1600 FAX: 610.647.2006
View Map | Get Directions

Access Information:
Handicap Access

hours icon Hours: Weekdays
 
Location:
Main Line Health Center in Collegeville
599 Arcola Road
Collegeville, PA  19426

TEL: 484.565.1600 FAX: 610.647.2006
View Map | Get Directions

Access Information:
Handicap Access

hours icon Hours: Weekdays
 
Location:
Main Line Health Center at Exton Square
154 Exton Square Parkway
Exton, PA  19341

TEL: 484.565.1600 FAX: 610.647.2006
View Map | Get Directions

Access Information:
Public Transportation, Handicap Access

hours icon Hours: Weekdays
 
MLHC Hematology & Oncology Associates
255 West Lancaster Avenue
Paoli, PA  19301

TEL: 484.565.1600 FAX: 610.647.2006

View Map | Get Directions

Access Information:
Handicap Access

Hours:Weekdays

MLHC Hematology & Oncology Associates
599 Arcola Road
Collegeville, PA  19426

TEL: 484.565.1600 FAX: 610.647.2006

View Map | Get Directions

Access Information:
Handicap Access

Hours:Weekdays

MLHC Hematology & Oncology Associates
154 Exton Square Parkway
Exton, PA  19341

TEL: 484.565.1600 FAX: 610.647.2006

View Map | Get Directions

Access Information:
Public Transportation, Handicap Access

Hours:Weekdays



Statement of Practice Philosophy

To provide the highest quality treatment possible in a supportive, caring environment, utilizing the most effective and innovative therapies, while focused on each individual's special needs and goals of care.

Titles

Clinical/Dept Titles:

Attending Physician

Recent Clinical Studies Published

PUBLICATIONS

Lewis, NL, Scher R, Gallo JM, Engstrom PF, Szarka CE, Litwin S, Adams AL, Kilpatrick D, Brady D, Weiner LM, Meropol NJ. Phase I and Pharmacokinetic Study of Irinotecan in Combination with Raltitrexed. Cancer Chemother. Pharmacol. 50:257-265, 2002.

Szarka CE, Hamilton TC, Klein-Szanto AJP, and Ozols RF. Chemoprevention of Ovarian Cancer. Ovarian Cancer, Oxford University Press, New York, NY pp. 153-160, 2002.

Szarka CE, Yao K-S, Pfeiffer GR, Balshem AM, Litwin S, Frucht H, Goosenberg E, Engstrom P, Clapper ML, and O’Dwyer PJ. Chronic Dosing of Oltipraz in People at Increased Risk for Colorectal Cancer. Cancer Detect. Prev. 25(4):352-361, 2001.

Sasson AR, Hoffman JP, Ross E, Meropol NJ, Szarka CE, Freedman G, Pinover W, Pingpank JF, Eisenberg BL, Trimodality Therapy for Advanced Gallbladder Cancer. Am. Surg. 67:277-284, 2001.

Hudes GR, Szarka CE, Adams A, Ranganathan S, McCauley RA, Weiner LM, Langer CJ, Litwin S, Yeslow G, Halbherr T, Qian M., and Gallo JM. Phase I Pharmacokinetic Trial of Perillyl Alcohol (NCS 641066) in Patients with Refractory Solid Malignancies Clin Cancer Res 6:3071-3080, 2000.

O’Dwyer PJ, Szarka C, Brennan JM, Laub PB, Gallo JM. Pharmacokinetics of the Chemopreventive Agent Oltipraz and of its Metabolite M3 in Human Subjects After a Single Oral Dose. Clinical Cancer Research 6(12):4692-4696, 2000.

Diefenbach MA, Szarka CE, Knowles JC, Clapper M, Miller SM, and Engstrom PE. Psychological Factors Associated with Participation and Retention in Lung Cancer Chemoprevention Trial. Cancer Detect. Prev.(under revision), 2000.

Szarka CE, Ehya H, Klein-Szanto A, Clapper M, Unger M, King E, Cecelia M, Andrew B, Gallo JM, Litwin S, Engstrom PF, Berg C. A Phase II Trial of Oltipraz as a Chemopreventive Agent for Lung Dysplasia. Proc. Am. Soc. Clin. Oncol. 19:1946, 2000.

Hudes G, Schol J, Baab J, Rogatko A, Bol C, Horak I, Langer C, Goldstein LJ, Szarka C, Meropol NJ, Weiner L. Phase I Clinical and Pharmacokinetic Trial of the Farnesyltransferase Inhibitor R115777 on a 21-day Dosing Schedule. Proc. Am.Soc. Clin. Oncol. 18:601, 1999.

 

Recent Honors, Awards, Citations

  • 2010 - "Top Doc" in Oncology/Hematology, Main Line Magazine
  • 2009 - "Top Doc" in Oncology/Hematology, Main Line Magazine
  • 1997-2001 - Member, Pennsylvania Cancer Control Prevention & Research Advisory Board

Personal Quote

Statement of Practice Philosophy:

To provide the highest quality treatment possible in a supportive, caring environment, utilizing the most effective and innovative therapies, while focused on each individual's special needs and goals of care.

Current Memberships and Activities

American Society of Clinical OncologyAmerican Association for Cancer ResearchAmerican College of PhysiciansPennsylvania Medical Society

GENERAL

Specialties: Oncology (Board Certified in 1995) - Accepting New Patients
Hematology/Oncology - Accepting New Patients
Gender: F
Years in practice: 22

Medical School:
Medical College of Pennsylvania

Residency:
Chandler Medical Center, University of Kentucky

Fellowship:
Fox Chase Cancer Center

Primary Affiliation:  Paoli Hospital

* Members of the Main Line Health medical staff are affiliated with Bryn Mawr Hospital, Lankenau Medical Center, Paoli Hospital and Riddle Hospital.

Titles

Clinical/Dept Titles:

Attending Physician


PRACTICE

Practice Name:
MLHC Hematology & Oncology Associates

appointment icon Locations:

Cancer Center of Paoli Hospital
255 West Lancaster Avenue
Paoli, PA  19301
TEL: 484.565.1600 FAX: 610.647.2006
transportation icon Access Information:  Handicap Access
hours icon Hours: Weekdays
Main Line Health Center in Collegeville
599 Arcola Road
Collegeville, PA  19426
TEL: 484.565.1600 FAX: 610.647.2006
transportation icon Access Information:  Handicap Access
hours icon Hours: Weekdays
Main Line Health Center at Exton Square
154 Exton Square Parkway
Exton, PA  19341
TEL: 484.565.1600 FAX: 610.647.2006
transportation icon Access Information:  Public Transportation,Handicap Access
hours icon Hours: Weekdays
Areas of Clinical Interest: Advanced treatment for all cancer diagnoses, including:
- GI Malignancies
- Breast Cancer

Statement of Practice Philosophy

To provide the highest quality treatment possible in a supportive, caring environment, utilizing the most effective and innovative therapies, while focused on each individual's special needs and goals of care.


PUBLICATIONS & CITATIONS

Recent Clinical Studies Published

PUBLICATIONS

Lewis, NL, Scher R, Gallo JM, Engstrom PF, Szarka CE, Litwin S, Adams AL, Kilpatrick D, Brady D, Weiner LM, Meropol NJ. Phase I and Pharmacokinetic Study of Irinotecan in Combination with Raltitrexed. Cancer Chemother. Pharmacol. 50:257-265, 2002.

Szarka CE, Hamilton TC, Klein-Szanto AJP, and Ozols RF. Chemoprevention of Ovarian Cancer. Ovarian Cancer, Oxford University Press, New York, NY pp. 153-160, 2002.

Szarka CE, Yao K-S, Pfeiffer GR, Balshem AM, Litwin S, Frucht H, Goosenberg E, Engstrom P, Clapper ML, and O’Dwyer PJ. Chronic Dosing of Oltipraz in People at Increased Risk for Colorectal Cancer. Cancer Detect. Prev. 25(4):352-361, 2001.

Sasson AR, Hoffman JP, Ross E, Meropol NJ, Szarka CE, Freedman G, Pinover W, Pingpank JF, Eisenberg BL, Trimodality Therapy for Advanced Gallbladder Cancer. Am. Surg. 67:277-284, 2001.

Hudes GR, Szarka CE, Adams A, Ranganathan S, McCauley RA, Weiner LM, Langer CJ, Litwin S, Yeslow G, Halbherr T, Qian M., and Gallo JM. Phase I Pharmacokinetic Trial of Perillyl Alcohol (NCS 641066) in Patients with Refractory Solid Malignancies Clin Cancer Res 6:3071-3080, 2000.

O’Dwyer PJ, Szarka C, Brennan JM, Laub PB, Gallo JM. Pharmacokinetics of the Chemopreventive Agent Oltipraz and of its Metabolite M3 in Human Subjects After a Single Oral Dose. Clinical Cancer Research 6(12):4692-4696, 2000.

Diefenbach MA, Szarka CE, Knowles JC, Clapper M, Miller SM, and Engstrom PE. Psychological Factors Associated with Participation and Retention in Lung Cancer Chemoprevention Trial. Cancer Detect. Prev.(under revision), 2000.

Szarka CE, Ehya H, Klein-Szanto A, Clapper M, Unger M, King E, Cecelia M, Andrew B, Gallo JM, Litwin S, Engstrom PF, Berg C. A Phase II Trial of Oltipraz as a Chemopreventive Agent for Lung Dysplasia. Proc. Am. Soc. Clin. Oncol. 19:1946, 2000.

Hudes G, Schol J, Baab J, Rogatko A, Bol C, Horak I, Langer C, Goldstein LJ, Szarka C, Meropol NJ, Weiner L. Phase I Clinical and Pharmacokinetic Trial of the Farnesyltransferase Inhibitor R115777 on a 21-day Dosing Schedule. Proc. Am.Soc. Clin. Oncol. 18:601, 1999.

 

Recent Honors, Awards, Citations

  • 2010 - "Top Doc" in Oncology/Hematology, Main Line Magazine
  • 2009 - "Top Doc" in Oncology/Hematology, Main Line Magazine
  • 1997-2001 - Member, Pennsylvania Cancer Control Prevention & Research Advisory Board

Personal Quote

Statement of Practice Philosophy:

To provide the highest quality treatment possible in a supportive, caring environment, utilizing the most effective and innovative therapies, while focused on each individual's special needs and goals of care.

Current Memberships and Activities

American Society of Clinical OncologyAmerican Association for Cancer ResearchAmerican College of PhysiciansPennsylvania Medical Society

Membership on the medical staff of any of our hospitals does not constitute an employment or agency relationship.

Compare Physicians
  •  

Connect with MLH

New Appointments
1.866.CALL.MLH

 Well Ahead Newsletter


STAY CONNECTED

Copyright 2014 Main Line Health

Printed from: www.mainlinehealth.org/PHY/Page.asp?PageID=PHY001444

The information provided in this Web site is for informational purposes only. It is not a substitute for medical advice. All medical information presented should be discussed with your healthcare professional. See additional Terms of Use at www.mainlinehealth.org/terms. For more information, call 1.866.CALL.MLH.